— Know what they know.
Not Investment Advice

ADCT NYSE

ADC Therapeutics S.A.
1W: +1.8% 1M: -16.4% 3M: -16.6% YTD: -2.8% 1Y: +59.1% 3Y: +40.2% 5Y: -83.9%
$3.39
-0.01 (-0.29%)
 
Weekly Expected Move ±5.5%
$3 $3 $3 $3 $4
NYSE · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $431.2M mcap · 98M float · 1.11% daily turnover · Short 47% of daily vol

📊 Key Metrics

TTM
$79M
Revenue
+4.4% YoY
$-137M
Net Income
+8.6% YoY
$-115M
Free Cash Flow
+16.2% YoY
82.7%
Gross Margin
-121.1%
Op. Margin
-158.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE70.5%
ROA-42.5%
ROIC1146.9%

Valuation

P/E-3.8
P/B-2.4
EV/EBITDA-8.6

Leverage

Debt/Equity-2.36
Current Ratio4.37
Interest Cov.-1.7x

Quality Scores

Piotroski F5/9
Altman Z-6.19
Beneish M10.03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms